Tatiana I. Novobrantseva

Author

Alnylam Pharmaceuticals (United States)ORCID

Also Known As

T I Novobrantseva, T NOVOBRANTSEVA, T Novobrantseva, T. I. Novobrantseva, T. Novobrantseva, Tatiana I Novobrantseva, Tatiana I. Novobrantseva, Tatiana Novobrantseva

101

Publications

6.4K

Citations

H-Index

Concepts

All Affiliations

Alnylam Pharmaceuticals (United States)Harvard University Massachusetts Institute of Technology Massachusetts General Hospital Center for Systems Biology

About

Tatiana I. Novobrantseva is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	2.3K
2	Engineering	6	6	1.7K
3	Biomedical Engineering	5	5	1.5K
4	Health Sciences	2	2	341
5	Natural Sciences	1	1	58

Tatiana I. Novobrantseva

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Therapeutic siRNA silencing in inflammatory monocytes in mice Florian Leuschner, Partha Dutta, Rostic Gorbatov, Nature Biotechnology InflammationAnti-inflammatoryAutoimmune DiseaseImmunologyTherapeutic Sirna	2011	825
Origins of tumor-associated macrophages and neutrophils Virna Cortez‐Retamozo, Martin Etzrodt, Andita Newton, Proceedings of the National Academy of Sciences	2012	672
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity Kathryn A. Whitehead, J. Robert Dorkin, Arturo J. Vegas, Nature Communications NanoparticlesNanomedicineEngineeringDegradable Lipid NanoparticlesTherapeutic Nanomaterials	2014	603
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight James E. Dahlman, Carmen Barnes, Omar F. Khan, Nature Nanotechnology NanoparticlesNanomedicineCell-based Drug DeliveryEngineeringLow Molecular Weight	2014	567
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates Yizhou Dong, Kevin T. Love, J. Robert Dorkin, Proceedings of the National Academy of Sciences	2014	470
Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production Annie‐Carole Tosello‐Trampont, Susan G. Landes, Virginia Nguyen, Journal of Biological Chemistry	2012	406
In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing Gabriel Courties, Timo Heidt, Matthew Sebas, Journal of the American College of Cardiology InflammationThrombopoiesisTranscriptional RegulationSignaling PathwayImmunology	2013	277
Attenuated liver fibrosis in the absence of B cells Tatiana I. Novobrantseva Journal of Clinical Investigation ImmunologyPathologyImmunologic MechanismCholangiopathiesImmunotherapy	2005	267
Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression Cristina López-Rodrı́guez, Christopher L. Antos, John M. Shelton, Proceedings of the National Academy of Sciences	2004	265
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery Daniel J. Siegwart, Kathryn A. Whitehead, Lutz Nuhn, Proceedings of the National Academy of Sciences NanoparticlesNanomedicineModular DesignEngineeringNanomaterials	2011	199

Page 1